Hematological Malignancies

Duration of response by disease group

FL (n=40); median 10.8 months SLL (n=17); median 12.5 months MZL (n=7); median 18.4 months LPL/WM (n=8); median not reached

(%)

Probability of continued response

Time from response (months)

40 17

24

10

4 3 1 3

3 2

9 4 6

5 2 4

Patients at risk, n

7 8

2

1